Catheter Precision Q4 EPS $(2.88) Up From $(21.66) YoY, Sales $238.000K Up From $149.000K YoY

Benzinga Newsdesk www.benzinga.com Negative 66.5%

Neg 66.5% Neu 0% Pos 0%

Catheter Precision (AMEX:VTAK) reported quarterly losses of $(2.88) per share. This is a 86.7 percent increase over losses of $(21.66) per share from the same period last year. The company reported $238.000 thousand in sales this quarter. This is a 59.73 percent increase over sales of $149.000 thousand the same period last year.